Advertisement

June 3, 2020

Sirtex Medical Appoints Dr. Mark Turco as Global Chief Medical Officer

June 3, 2020––Sirtex Medical US Holdings, Inc. announced the appointment of Mark A. Turco, MD, as Global Chief Medical Officer and Executive Vice President of Research & Development, effective June 1, 2020. Sirtex is focused on targeted radiation therapies for liver cancer, including SIR-Spheres yttrium-90 resin microspheres. The company has global headquarters in Woburn, Massachusetts.

Dr. Turco will serve as the company’s principal medical expert and corporate leader of medical and clinical affairs. He will develop the strategic vision for Sirtex’s clinical trial portfolio, including registration and postregistration trials. Dr. Turco will also be responsible for ensuring the accuracy of medical input, building the company’s research and development function, and developing key external relationships.

Kevin R. Smith, Chief Executive Officer of Sirtex, stated in the company’s announcement, “Dr. Turco brings an extraordinary, diverse background as a board-certified interventional cardiologist, clinical researcher, and health care and business executive, as well as expertise in academic innovation. We’re thrilled to welcome him to the team, and we look forward to working together to further our mission of patient-first oncology innovation.”

Dr. Turco commented, “It’s an honor to join Sirtex at this important time of advancing our clinical trial portfolio and driving product growth. I’m excited to join this outstanding team as we deliver the best therapies to patients living with cancer and beyond.”

Before joining Sirtex, Dr. Turco served as Chief Innovation and Corporate Outreach Officer for the University of Pennsylvania’s Penn Center for Innovation in Philadelphia, Pennsylvania. Previously, he was Vice President and Chief Medical Officer for the Aortic, Peripheral, and Vascular Divisions at Medtronic. Dr. Turco joined Medtronic in its acquisition of Covidien, where he served as Chief Medical Officer. Earlier, Dr. Turco was Director of the Center for Cardiac and Vascular Research at Washington Adventist Hospital in Takoma Park, Maryland.

Advertisement


June 3, 2020

AndraTec's Optimus CVS and Optimus XL Vascular Stents Approved in Europe

June 2, 2020

JVS Study Compares Long-Term Outcomes of EVAR and Open Repair to Treat rAAA